ABP 215
Names
[ CAS No. ]:
1438851-35-4
[ Name ]:
ABP 215
Biological Activity
[Description]:
ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab (HY-P9906)) biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research[1][2].
[Related Catalog]:
[In Vitro]
ABP 215 (Bevacizumab-awwb) 与 VEGF-A 结合,阻止 VEGF-A 与内皮细胞表面的 VEGF 受体结合,抑制内皮细胞增殖和新血管形成,从而导致肿瘤脉管系统正常化。
[References]
Chemical & Physical Properties
No Any Chemical & Physical Properties